Cargando…

Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge

Background: Retinal ischaemia is present to a greater or lesser extent in all eyes with diabetic retinopathy (DR). Nonetheless, our understanding of its pathogenic mechanisms, risk factors, as well as other characteristics of retinal ischaemia in DR is very limited. To date, there is no treatment to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohite, Ajay A., Perais, Jennifer A., McCullough, Philip, Lois, Noemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056455/
https://www.ncbi.nlm.nih.gov/pubmed/36983406
http://dx.doi.org/10.3390/jcm12062406
_version_ 1785016125708304384
author Mohite, Ajay A.
Perais, Jennifer A.
McCullough, Philip
Lois, Noemi
author_facet Mohite, Ajay A.
Perais, Jennifer A.
McCullough, Philip
Lois, Noemi
author_sort Mohite, Ajay A.
collection PubMed
description Background: Retinal ischaemia is present to a greater or lesser extent in all eyes with diabetic retinopathy (DR). Nonetheless, our understanding of its pathogenic mechanisms, risk factors, as well as other characteristics of retinal ischaemia in DR is very limited. To date, there is no treatment to revascularise ischaemic retina. Methods: Review of the literature highlighting the current knowledge on the topic of retinal ischaemia in DR, important observations made, and underlying gaps for which research is needed. Results: A very scarce number of clinical studies, mostly cross-sectional, have evaluated specifically retinal ischaemia in DR. Interindividual variability on its natural course and consequences, including the development of its major complications, namely diabetic macular ischaemia and proliferative diabetic retinopathy, have not been investigated. The in situ, surrounding, and distance effect of retinal ischaemia on retinal function and structure and its change over time remains also to be elucidated. Treatments to prevent the development of retinal ischaemia and, importantly, to achieve retinal reperfusion once capillary drop out has ensued, are very much needed and remain to be developed. Conclusion: Research into retinal ischaemia in diabetes should be a priority to save sight.
format Online
Article
Text
id pubmed-10056455
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100564552023-03-30 Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge Mohite, Ajay A. Perais, Jennifer A. McCullough, Philip Lois, Noemi J Clin Med Review Background: Retinal ischaemia is present to a greater or lesser extent in all eyes with diabetic retinopathy (DR). Nonetheless, our understanding of its pathogenic mechanisms, risk factors, as well as other characteristics of retinal ischaemia in DR is very limited. To date, there is no treatment to revascularise ischaemic retina. Methods: Review of the literature highlighting the current knowledge on the topic of retinal ischaemia in DR, important observations made, and underlying gaps for which research is needed. Results: A very scarce number of clinical studies, mostly cross-sectional, have evaluated specifically retinal ischaemia in DR. Interindividual variability on its natural course and consequences, including the development of its major complications, namely diabetic macular ischaemia and proliferative diabetic retinopathy, have not been investigated. The in situ, surrounding, and distance effect of retinal ischaemia on retinal function and structure and its change over time remains also to be elucidated. Treatments to prevent the development of retinal ischaemia and, importantly, to achieve retinal reperfusion once capillary drop out has ensued, are very much needed and remain to be developed. Conclusion: Research into retinal ischaemia in diabetes should be a priority to save sight. MDPI 2023-03-21 /pmc/articles/PMC10056455/ /pubmed/36983406 http://dx.doi.org/10.3390/jcm12062406 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mohite, Ajay A.
Perais, Jennifer A.
McCullough, Philip
Lois, Noemi
Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge
title Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge
title_full Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge
title_fullStr Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge
title_full_unstemmed Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge
title_short Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge
title_sort retinal ischaemia in diabetic retinopathy: understanding and overcoming a therapeutic challenge
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056455/
https://www.ncbi.nlm.nih.gov/pubmed/36983406
http://dx.doi.org/10.3390/jcm12062406
work_keys_str_mv AT mohiteajaya retinalischaemiaindiabeticretinopathyunderstandingandovercomingatherapeuticchallenge
AT peraisjennifera retinalischaemiaindiabeticretinopathyunderstandingandovercomingatherapeuticchallenge
AT mcculloughphilip retinalischaemiaindiabeticretinopathyunderstandingandovercomingatherapeuticchallenge
AT loisnoemi retinalischaemiaindiabeticretinopathyunderstandingandovercomingatherapeuticchallenge